B. 1. Block, G. Hulbert-shearon, T. Levin, N. Port, and F. , Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study, American Journal of Kidney Diseases, vol.31, issue.4
DOI : 10.1053/ajkd.1998.v31.pm9531176

G. Block, P. Klassen, J. Lazarus, N. Ofsthun, E. Lowrie et al., Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis, Journal of the American Society of Nephrology, vol.15, issue.8, pp.2208-2218, 2004.
DOI : 10.1097/01.ASN.0000133041.27682.A2

F. Tentori, M. Blayney, J. Albert, B. Gillespie, P. Kerr et al., Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS), American Journal of Kidney Diseases, vol.52, issue.3, pp.519-530, 2008.
DOI : 10.1053/j.ajkd.2008.03.020

C. Kumata, M. Mizobuchi, H. Ogata, F. Koiwa, A. Nakazawa et al., Involvement of Alpha-Klotho and Fibroblast Growth Factor Receptor in the Development of Secondary Hyperparathyroidism, American Journal of Nephrology, vol.31, issue.3, pp.230-238, 2010.
DOI : 10.1159/000274483

E. Cavalier, P. Delanaye, L. Vranken, A. Bekaert, A. Carlisi et al., Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values, Nephrology Dialysis Transplantation, vol.55, issue.9, pp.1950-1956, 2012.
DOI : 10.1373/clinchem.2008.121921

J. Souberbielle, H. Roth, and D. Fouque, Parathyroid hormone measurement in CKD, Kidney International, vol.77, issue.2, pp.93-100, 2010.
DOI : 10.1038/ki.2009.374

J. Souberbielle, F. Bienaimé, E. Cavalier, and C. Cormier, Vitamin D and primary hyperparathyroidism (PHPT), Annales d'Endocrinologie, vol.73, issue.3, pp.165-169, 2012.
DOI : 10.1016/j.ando.2012.04.008

J. Ennis, E. Worcester, and F. Coe, Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD, Nephrology Dialysis Transplantation, vol.87, issue.7
DOI : 10.1007/s00223-010-9397-5

H. Malluche, H. Mawad, and M. Monier-faugere, Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients):1368?1376. 11. Gal-Moscovici A, Popovtzer MM. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels, J. Bone Miner. Res. juin Clin. Nephrol. avr, vol.2663, issue.64, pp.284-289, 2005.

D. Hartenbower, A. Norman, and J. Coburn, Actions of 1 alphahydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on mineral metabolism in man. I. Effects on net absorption of phosphorus):1064?1069. 14. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Kidney Int, 771?777. 13. Brickman AS, pp.1-130, 1977.

N. Thilly, S. Boini, M. Kessler, S. Briançon, and L. Frimat, Chronic kidney disease: appropriateness of therapeutic management and associated factors in the AVENIR study, 121?8. 16. Ureña Torres P. What are the actual indications for a surgical parathiroidectomy, 2009.
DOI : 10.1111/j.1365-2753.2008.00965.x

N. Parathyroidectomy and . Tm, KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism, Langenbecks Arch Surg. mars, vol.397, issue.3, pp.413-420, 2012.

G. Strippoli, S. Palmer, A. Tong, G. Elder, P. Messa et al., Meta-analysis of biochemical and patient-level effects of calcimimetic therapy The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism, Am. J. Kidney Dis. mai Clin J Am Soc Nephrol. janv, vol.473, issue.201, pp.36-45, 2006.

G. Jean, J. Souberbielle, C. Lorriaux, B. Mayor, J. Hurot et al., Les formes cliniques et biologiques de l???hyperparathyro??die secondaire en dialyse, N??phrologie & Th??rapeutique, vol.8, issue.1, pp.35-40, 2012.
DOI : 10.1016/j.nephro.2011.05.002

K. Martin and E. González, Long-term Management of CKD???Mineral and Bone Disorder, American Journal of Kidney Diseases, vol.60, issue.2
DOI : 10.1053/j.ajkd.2012.01.027

J. Pasieka, L. Parsons, J. Pasieka, L. Parsons, M. Demeure et al., Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism):513?518; discussion 518?519. 34. Pasieka JL, Parsons LL. A prospective surgical outcome study assessing the impact of parathyroidectomy on symptoms in patients with secondary and tertiary hyperparathyroidism Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism, Kidney Dis. août World J Surg. juin Surgery. oct World J Surg. août, vol.602212826, issue.358, pp.308-315, 1998.

S. Boini, A. Leplege, L. Ayav, C. Français, P. Ecosse et al., Mesure de??la??qualit?? de??vie dans??l'insuffisance r??nale chronique terminale, N??phrologie & Th??rapeutique, vol.3, issue.6, pp.372-383, 2007.
DOI : 10.1016/j.nephro.2007.05.005

B. Gandek, J. Ware, N. Aaronson, G. Apolone, J. Bjorner et al., Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries, 1171?1178. 38 Multivariate descriptive statistical analysis, 1984.
DOI : 10.1016/S0895-4356(98)00109-7

J. Neyman, J. Statistics-fernández-martín, J. Carrero, M. Benedik, W. Bos et al., COSMOS: the dialysis scenario of CKD-MBD in Europe Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS), sept Nephrol. Dial. Transplant. Nephrol. Dial. Transplant. janv Nephrol. Ther. sept, vol.122198, issue.1, pp.108-120, 1955.

R. Venkat, G. Kouniavsky, R. Tufano, E. Schneider, A. Dackiw et al., Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study, 55?60. 45. Pasieka JL, Parsons, pp.1006-1013, 2009.

P. Malindretos, P. Sarafidis, A. Lazaridis, and P. Nikolaidis, A study of the association of higher parathormone levels with health-related quality of life in hemodialysis patients, Clinical Nephrology, vol.77, issue.03, pp.196-203, 2012.
DOI : 10.5414/CN107030

J. Cunningham, M. Danese, K. Olson, P. Klassen, G. Chertow et al., Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up) The Kidney, 153?159; discussion 159?160. 49. Noordzij M, 2005.

S. Pelletier, H. Roth, J. Bouchet, T. Drueke, G. London et al., Mineral and bone disease pattern in elderly haemodialysis patients, Nephrology Dialysis Transplantation, vol.72, issue.9, pp.3062-3070, 2010.
DOI : 10.1038/sj.ki.5002466

R. Garside, M. Pitt, R. Anderson, S. Mealing, C. Roome et al., The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation, iii, xi?xiii, 1?167. 53. Naves-Díaz M, Passlick-Deetjen J, 2007.
DOI : 10.3310/hta11180

D. Puyol, Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from

L. America, ):1938?1947. 54. Perkovic V, Neal B. Trials in Kidney Disease -Time to EVOLVE, The CORES Study. Nephrol. Dial. Transplant. juin N. Engl. J. Med. 3 nov, vol.26, issue.6, 2011.